Cost minimization of Medicare Part D prescription drug plan expenditures

American Journal of Managed Care

Volumn 15, Issue 8, 2009, Pages 545-553

  Patel, Rajul A ^a   Lipton, Helene Levens ^b   Cutler, Timothy W ^b   Smith, Amanda R ^b   Tsunoda, Shirley M ^c   Stebbins, Marilyn R ^b  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; COST CONTROL; COST MINIMIZATION ANALYSIS; DATA COLLECTION METHOD; DEMOGRAPHY; DRUG COST; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INTERVENTION STUDY; MALE; MEDICAID; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL SCHOOL; MEDICAL STUDENT; MEDICARE; PATIENT SELECTION; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

AGED; CALIFORNIA; COMMUNITY-INSTITUTIONAL RELATIONS; CONSUMER HEALTH INFORMATION; COST SAVINGS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSURANCE BENEFITS; MALE; MEDICARE PART D; PATIENT EDUCATION AS TOPIC; PRESCRIPTION DRUGS; STUDENTS, PHARMACY; UNITED STATES;

EID: 69749119164     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Centers for Medicare & Medicaid Services, Department of Health and Human Services. Key milestones in CMS programs. October 7, 2004. http://www.cms.hhs.gov/History/Downloads/CMSProgramKeyMilestones.pdf. Accessed April 29, 2008.
2. Kaiser Family Foundation. The Medicare Prescription Drug Benefit. Washington, DC: Kaiser Family Foundation; 2008. Publication 7044-7108
3. Kaiser Family Foundation. Medicare Prescription Drug Coverage Among Medicare Beneficiaries. Washington, DC: Kaiser Family Foundation; 2006. Publication 7453.
4. Lichtenberg FR, Sun SX.The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood). 2007;26(6):1735-1744.
5. Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff (Millwood). 2007;26(5):w630-w643.
6. Hoadley J, Hargrave E, Cubanski J, Neuman T. The Medicare Part D Coverage Gap: Costs and Consequences in 2007. Washington, DC: Kaiser Family Foundation; 2008.
7. Summer L, Nemore P, Finberg J. Improving the Medicare Part D program for the most vulnerable beneficiaries. May 2007. http://www.commonwealthfund.org/ publications/publications-show.htm?doc-id=484282. Accessed April 29, 2008.
8. Tan RL. Medicare beneficiaries' use of computers and Internet: 1998-2005. Health Care Financ Rev. 2006;28(2):45-51. http://www.cms.hhs.gov/ HealthCareFinancingReview/downloads/06-07Winpg45.pdf. Accessed April 29, 2008.
9. Czaja SJ, Sharit J, Nair SN. Usability of the Medicare health Web site. JAMA. 2008;300(7):790-792.
10. AACP Commission to Implement Change in Pharmaceutical Education. What is the mission of pharmaceutical education? http://www.aacp.org/docs/ mainnavigation/educationalresources/3586-backgroundpaper1.pdf. http://www.aacp.org/resources/historicaldocuments/Documents/BackgroundPaper1. pdf Accessed July 17, 2009.
11. Accreditation Council for Pharmacy Education. Accreditation standards and guidelines for the professional program in pharmacy leading to the Doctor of Pharmacy degree. http://www.acpe-accredit.org/pdf/ACPE-Revised-PharmD-Standards- Adopted-Jan152006.DOC. Accessed April 29, 2008.
12. PubMedWeb site. PubMed home. http://www.ncbi.nlm.nih.gov/pubmed. Accessed March 12, 2008.
13. SCOPUS Web site. Scopus marketing homepage. http://www.scopus.com/scopus/ home.url. Accessed March 12, 2008.
14. Narine L, Hague LK, Walker JH, et al. Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension. Curr Med Res Opin. 2005;21(12):2007-2016. (Pubitemid 41803112)
15. Kruep EJ, Basskin LE. Cost-minimization analysis of darbepoetin alfa versus epoetin alfa in the hospital setting. Am J Health Syst Pharm. 2005;62(24):2597-2603.
16. Samsa GP, Matchar DB, Harnett J, Wilson J. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. Chest. 2005;128(5):3246-3254. (Pubitemid 41698647)
17. Ergun H, Gulmez SE, Tulunay FC. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis. Eur Neurol. 2007;58(4):215-217. (Pubitemid 350175888)
18. Vergnenegre A, Combescure C, Fournel P, et al; GFPC (Groupe Français de Pneumo-Cancérologie). Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95-01). Ann Oncol. 2006;17(8):1269-1274.
19. KRC Research. Seniors' opinions about Medicare Rx: second year update: key findings. October 2007. http://www.medicaretoday.org/survey.pdf. Accessed July 7, 2008.